"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Endologix, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Endologix, Inc.
Has Endologix Inc (NASDAQ:ELGX) Improved Earnings Growth In Recent Times?
- Apr 10th, 2018 6:15 pm
Endologix, Inc. to Announce First Quarter 2018 Financial Results on May 2, 2018
- Apr 3rd, 2018 2:01 pm
Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems
- Mar 19th, 2018 2:01 pm
Will Endologix Inc’s (NASDAQ:ELGX) Earnings Grow In The Year Ahead?
- Mar 19th, 2018 11:26 am
Endologix, Inc. Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix® EndoVascular Aneurysm Sealing System
- Mar 5th, 2018 6:00 am
Free Research Report as Haemonetics’ Revenues Grew 2.7% and Adjusted EPS Surged 44%
- Mar 5th, 2018 5:50 am
What You Must Know About Endologix Inc’s (NASDAQ:ELGX) Financial Strength
- Feb 28th, 2018 12:51 pm
Edited Transcript of ELGX earnings conference call or presentation 21-Feb-18 9:30pm GMT
- Feb 22nd, 2018 10:10 am
Endologix reports 4Q loss
- Feb 21st, 2018 3:09 pm
John McDermott Steps Down as Chief Executive Officer of Endologix, Inc.
- Feb 21st, 2018 2:01 pm
Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results
- Feb 21st, 2018 2:00 pm
Endologix, Inc. to Host Earnings Call
- Feb 21st, 2018 10:00 am
Endologix Q4 Earnings Preview
- Feb 21st, 2018 8:50 am
Detailed Research: Economic Perspectives on Haemonetics, Endologix, NRG Yield, Cirrus Logic, Macquarie Infrastructure, and Shake Shack — What Drives Growth in Today's Competitive Landscape
- Feb 12th, 2018 6:15 am
Endologix, Inc. Completes Patient Enrollment in the ELEVATE IDE Clinical Study
- Feb 5th, 2018 6:00 am
Endologix, Inc. to Present at the Leerink Partners 7th Annual Global Healthcare Conference
- Jan 30th, 2018 2:01 pm
Endologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Jan 29th, 2018 6:00 am
Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018
- Jan 25th, 2018 2:01 pm
At $4.27, Is It Time To Buy Endologix Inc (NASDAQ:ELGX)?
- Jan 19th, 2018 10:25 am
Does Endologix Inc’s (NASDAQ:ELGX) Earnings Growth Make It An Outperformer?
- Jan 4th, 2018 12:10 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2018 VentureLine
Website developed by Digital Solutions